Cryosite Ltd (CTE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cryosite Ltd (CTE) has a cash flow conversion efficiency ratio of 0.361x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$1.30 Million ≈ $921.96K USD) by net assets (AU$3.61 Million ≈ $2.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CTE market cap overview for the company's overall valuation and market capitalisation.
Cryosite Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Cryosite Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cryosite Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cryosite Ltd ranked by their cash flow conversion efficiency. Explore Cryosite Ltd (CTE) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Granite Point Mortgage Trust Inc
NYSE:GPMT
|
-0.004x |
|
Joong Ang Enervis Co. Ltd
KQ:000440
|
-0.004x |
|
Incross Co. Ltd
KQ:216050
|
0.093x |
|
Strategic Investments A/S
CO:STRINV
|
0.097x |
|
Estoril Sol SGPS SA
LS:ESON
|
0.102x |
|
Indah Prakasa Sentosa PT Tbk
JK:INPS
|
-0.124x |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
0.085x |
|
SGC eTEC E&C Co. Ltd
KQ:016250
|
-0.045x |
Annual Cash Flow Conversion Efficiency for Cryosite Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Cryosite Ltd from 2001 to 2025. View Cryosite Ltd (CTE) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$2.39 Million ≈ $1.69 Million |
AU$2.06 Million ≈ $1.46 Million |
0.864x | -54.36% |
| 2024-06-30 | AU$1.45 Million ≈ $1.03 Million |
AU$2.74 Million ≈ $1.94 Million |
1.893x | +274.03% |
| 2023-06-30 | AU$2.78 Million ≈ $1.97 Million |
AU$1.41 Million ≈ $996.25K |
0.506x | -62.25% |
| 2022-06-30 | AU$1.86 Million ≈ $1.32 Million |
AU$2.49 Million ≈ $1.77 Million |
1.341x | +130.27% |
| 2021-06-30 | AU$819.23K ≈ $579.65K |
AU$476.96K ≈ $337.48K |
0.582x | -93.10% |
| 2020-06-30 | AU$154.88K ≈ $109.58K |
AU$1.31 Million ≈ $924.35K |
8.435x | +2135.42% |
| 2019-06-30 | AU$-1.72 Million ≈ $-1.21 Million |
AU$-647.54K ≈ $-458.17K |
0.377x | +379.99% |
| 2018-06-30 | AU$1.94 Million ≈ $1.38 Million |
AU$-261.91K ≈ $-185.32K |
-0.135x | -126.08% |
| 2017-06-30 | AU$3.15 Million ≈ $2.23 Million |
AU$1.63 Million ≈ $1.15 Million |
0.517x | +267.77% |
| 2016-06-30 | AU$3.38 Million ≈ $2.39 Million |
AU$474.61K ≈ $335.82K |
0.140x | -64.86% |
| 2015-06-30 | AU$3.54 Million ≈ $2.51 Million |
AU$1.42 Million ≈ $1.00 Million |
0.400x | +54.74% |
| 2014-06-30 | AU$6.14 Million ≈ $4.34 Million |
AU$1.58 Million ≈ $1.12 Million |
0.258x | -16.57% |
| 2013-06-30 | AU$6.26 Million ≈ $4.43 Million |
AU$1.94 Million ≈ $1.37 Million |
0.310x | -9.74% |
| 2012-06-30 | AU$5.48 Million ≈ $3.88 Million |
AU$1.88 Million ≈ $1.33 Million |
0.343x | +13.39% |
| 2011-06-30 | AU$4.69 Million ≈ $3.32 Million |
AU$1.42 Million ≈ $1.00 Million |
0.303x | +34.76% |
| 2010-06-30 | AU$4.35 Million ≈ $3.08 Million |
AU$977.66K ≈ $691.75K |
0.225x | +37.27% |
| 2009-06-30 | AU$4.34 Million ≈ $3.07 Million |
AU$709.86K ≈ $502.27K |
0.164x | -20.44% |
| 2008-06-30 | AU$4.32 Million ≈ $3.06 Million |
AU$888.27K ≈ $628.51K |
0.206x | +10.08% |
| 2007-06-30 | AU$3.74 Million ≈ $2.64 Million |
AU$697.65K ≈ $493.63K |
0.187x | +358.76% |
| 2006-06-30 | AU$2.81 Million ≈ $1.99 Million |
AU$-203.02K ≈ $-143.65K |
-0.072x | +10.55% |
| 2005-06-30 | AU$2.48 Million ≈ $1.75 Million |
AU$-199.90K ≈ $-141.44K |
-0.081x | +66.81% |
| 2004-06-30 | AU$3.04 Million ≈ $2.15 Million |
AU$-738.72K ≈ $-522.69K |
-0.243x | +20.88% |
| 2002-06-30 | AU$3.89 Million ≈ $2.75 Million |
AU$-1.20 Million ≈ $-845.61K |
-0.307x | -27.31% |
| 2001-06-30 | AU$3.87 Million ≈ $2.74 Million |
AU$-933.52K ≈ $-660.52K |
-0.241x | -- |
About Cryosite Ltd
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial … Read more